Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Short-Term Debt issuances: 2022-2023

Historic Short-Term Debt issuances for Roivant Sciences (ROIV) over the last 2 years, with Mar 2023 value amounting to $159.9 million.

  • Roivant Sciences' Short-Term Debt issuances rose 339.28% to $159.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was $392.6 million, marking a year-over-year change of. This contributed to the annual value of $159.9 million for FY2023, which is 339.28% up from last year.
  • As of FY2023, Roivant Sciences' Short-Term Debt issuances stood at $159.9 million, which was up 339.28% from $36.4 million recorded in FY2022.
  • Over the past 5 years, Roivant Sciences' Short-Term Debt issuances peaked at $159.9 million during FY2023, and registered a low of $36.4 million during FY2022.
  • In the last 2 years, Roivant Sciences' Short-Term Debt issuances had a median value of $98.1 million in 2022 and averaged $98.1 million.
  • Data for Roivant Sciences' Short-Term Debt issuances shows a peak YoY skyrocketed of 339.28% (in 2023) over the last 5 years.
  • Roivant Sciences' Short-Term Debt issuances (Yearly) stood at $36.4 million in 2022, then surged by 339.28% to $159.9 million in 2023.